Haimbaugh Alex, Meyer Danielle N, Connell Mackenzie L, Blount-Pacheco Jessica, Tolofari Dienye, Gonzalez Gabrielle, Banerjee Dayita, Norton John, Miller Carol J, Baker Tracie R
Department of Pharmacology, Wayne State University, Detroit, MI 48202, USA.
Department of Environmental and Global Health, University of Florida, Gainesville, FL 32611, USA.
Int J Environ Res Public Health. 2024 Dec 2;21(12):1615. doi: 10.3390/ijerph21121615.
This Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) systematic review synthesized effects of background levels of per- and polyfluorylalkyl substance (PFAS) levels on reproductive health outcomes in the general public: fertility, preterm birth, miscarriage, ovarian health, menstruation, menopause, sperm health, and in utero fetal growth. The inclusion criteria included original research (or primary) studies, human subjects, and investigation of outcomes of interest following non-occupational exposures. It drew from four databases (Web of Science, PubMed, Embase and Health and Environmental Research Online (HERO)) using a standardized search string for all studies published between 1 January 2017 and 13 April 2022. Risk of bias was assessed by two independent reviewers. Data were extracted and reviewed by multiple reviewers. Each study was summarized under its outcome in terms of methodology and results and placed in context, with recommendations for future research. Of 1712 records identified, 30 were eligible, with a total of 27,901 participants (33 datasets, as three studies included multiple outcomes). There was no effect of background levels of PFAS on fertility. There were weakly to moderately increased odds of preterm birth with higher perfluorooctane sulfonic acid (PFOS) levels; the same for miscarriage with perfluorooctanoic acid (PFOA) levels. There was limited yet suggestive evidence for a link between PFAS and early menopause and primary ovarian insufficiency; menstrual cycle characteristics were inconsistent. PFAS moderately increased odds of PCOS- and endometriosis-related infertility, respectively. Sperm motility and DNA health were moderately impaired by multiple PFAS. Fetal growth findings were inconsistent. This review may be used to inform forthcoming drinking water standards and policy initiatives regarding PFAS compounds and drinking water. Future reviews would benefit from more recent studies. Larger studies in these areas are warranted. Future studies should plan large cohorts and open access data availability to capture small effects and serve the public. Funding: Great Lakes Water Authority (Detroit, MI), the Erb Family Foundation through Healthy Urban Waters at Wayne State University (Detroit, MI), and Wayne State University CLEAR Superfund Research (NIH P42ES030991).
本系统评价遵循系统评价与Meta分析的首选报告项目(PRISMA),综合分析了全氟和多氟烷基物质(PFAS)背景水平对普通人群生殖健康结局的影响:生育能力、早产、流产、卵巢健康、月经、更年期、精子健康以及子宫内胎儿生长。纳入标准包括原始研究(或初级)研究、人类受试者以及对非职业暴露后感兴趣结局的调查。研究使用标准化检索式从四个数据库(科学网、PubMed、Embase和健康与环境研究在线数据库(HERO))中检索2017年1月1日至2022年4月13日期间发表的所有研究。由两名独立评审员评估偏倚风险。数据由多名评审员提取和审核。每项研究根据其结局在方法学和结果方面进行总结,并结合背景情况进行阐述,同时给出未来研究的建议。在识别出的1712条记录中,30条符合条件,共有27901名参与者(33个数据集,因为三项研究包含多个结局)。PFAS背景水平对生育能力没有影响。全氟辛烷磺酸(PFOS)水平较高时,早产几率有轻度到中度增加;全氟辛酸(PFOA)水平较高时,流产几率情况相同。PFAS与早期更年期和原发性卵巢功能不全之间存在关联的证据有限但具有提示性;月经周期特征不一致。PFAS分别使多囊卵巢综合征(PCOS)和子宫内膜异位症相关不孕几率中度增加。多种PFAS会中度损害精子活力和DNA健康状况。胎儿生长方面的研究结果不一致。本综述可用于为即将出台的关于PFAS化合物和饮用水的饮用水标准及政策举措提供参考。未来的综述将受益于更新的研究。这些领域需要开展更大规模的研究。未来的研究应规划大型队列研究并提供开放获取的数据,以捕捉微小影响并服务公众。资金来源:大湖水务局(密歇根州底特律)、厄尔布家族基金会通过韦恩州立大学(密歇根州底特律)的健康城市水域项目以及韦恩州立大学的清除超级基金研究项目(美国国立卫生研究院P42ES030991)。